CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma

por Gao, Yan, Feng, Yong, Shen, Jacson K., Lin, Min, Choy, Edwin, Cote, Gregory M., Harmon, David C., Mankin, Henry J., Hornicek, Francis J., Duan, Zhenfeng
Publicado 2015

Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy

por Choy, Edwin, Butrynski, James E, Harmon, David C, Morgan, Jeffrey A, George, Suzanne, Wagner, Andrew J, D’Adamo, David, Cote, Gregory M, Flamand, Yael, Benes, Cyril H, Haber, Daniel A, Baselga, Jose M, Demetri, George D
Publicado 2014